(MCHX) Marchex - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US56624R1086
MCHX: Conversation, Analytics, Marketing, AI, Messaging
Marchex, Inc. (NASDAQ:MCHX) is a conversation intelligence company specializing in conversational analytics and AI-driven solutions for businesses across the United States, Canada, and international markets. Its product suite includes Marketing Edge, which tracks inbound call campaigns, evaluates conversation outcomes, and links marketing efforts to sales conversions; Sonar Business Text Messaging, an AI-powered mobile messaging platform enabling personalized communication between teams, prospects, and customers; Marchex Platform Services, an API-based product that integrates AI insights into customer calls across various platforms; Spotlight, an AI conversation analytics tool tailored for multi-location businesses; and Engage, a solution designed to enhance performance at individual business locations. Founded in 2003, Marchex operates from its headquarters in Seattle, Washington.
Over the next three months, Marchex (MCHX) is expected to maintain a stable trading range near its current price of $1.96, with support from its SMA 50 at $1.97 and resistance near $2.00. The low ATR of 0.09 indicates minimal volatility, suggesting a sideways trend unless driven by external catalysts. Fundamentally, Marchexs forward P/S ratio of 1.76 reflects moderate valuation, while the negative RoE of -16.95 highlights ongoing profitability challenges. The companys focus on AI-driven solutions and multi-location business analytics could position it for growth, but execution and profitability improvements will remain key factors for investors.
Additional Sources for MCHX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MCHX Stock Overview
Market Cap in USD | 86m |
Sector | Communication Services |
Industry | Advertising Agencies |
GiC Sub-Industry | Advertising |
IPO / Inception | 2004-03-31 |
MCHX Stock Ratings
Growth 5y | 12.1% |
Fundamental | -45.2% |
Dividend | 8.83% |
Rel. Strength Industry | 21.5 |
Analysts | 4.5/5 |
Fair Price Momentum | 1.86 USD |
Fair Price DCF | - |
MCHX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 29.4% |
MCHX Growth Ratios
Growth Correlation 3m | 1.6% |
Growth Correlation 12m | 83.6% |
Growth Correlation 5y | -35.8% |
CAGR 5y | 3.58% |
CAGR/Max DD 5y | 0.05 |
Sharpe Ratio 12m | -0.08 |
Alpha | 40.53 |
Beta | 1.17 |
Volatility | 47.49% |
Current Volume | 20.5k |
Average Volume 20d | 47.4k |
As of March 18, 2025, the stock is trading at USD 1.98 with a total of 20,546 shares traded.
Over the past week, the price has changed by -1.00%, over one month by -0.50%, over three months by -3.88% and over the past year by +46.67%.
Probably not. Based on ValueRay Fundamental Analyses, Marchex (NASDAQ:MCHX) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -45.23 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCHX as of March 2025 is 1.86. This means that MCHX is currently overvalued and has a potential downside of -6.06%.
Marchex has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy MCHX.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, MCHX Marchex will be worth about 2.1 in March 2026. The stock is currently trading at 1.98. This means that the stock has a potential upside of +7.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3.3 | 64.1% |
Analysts Target Price | 3.3 | 64.1% |
ValueRay Target Price | 2.1 | 7.6% |